Neoadjuvant Chemotherapy and Local Radiotherapy for High-Grade Osteosarcoma of the Extremities

Machak, Gennady N.; Tkachev, Sergey I.; Solovyev, Yuriy N.; Sinyukov, Pavel A.; Ivanov, Stanislav M.; Kochergina, Natalya V.; Rykov, Alexey D.; Tepliakov, Valery V.; Bokhian, Benjamin Y.; Glebovskaya, Valeria V.
February 2003
Mayo Clinic Proceedings;Feb2003, Vol. 78 Issue 2, p147
Academic Journal
Determines the effectiveness of radiation therapy for local control of nonmetastatic osteosarcoma of the extremities after induction chemotherapy. Finding that radiation therapy can be a reliable modality to control local disease and preserve limb function when used after effective induction chemotherapy for osteosarcoma of the extremities.


Related Articles

  • Effectiveness of Radiotherapy for Osteosarcoma That Responds to Chemotherapy. Anderson, Peter M. // Mayo Clinic Proceedings;Feb2003, Vol. 78 Issue 2, p145 

    Examines the effectiveness of radiotherapy for osteosarcoma that responds to chemotherapy. Standard of care for osteosarcoma; Prognosis for patients with osteosarcoma; Potential benefit of available radiation techniques for bone-forming osteosarcoma tumors; Challenges in the search for...

  • Non Surgical Treatment of Sacral Osteosarcoma. Aledavood, S. A.; Amirabadi, A.; Memar, B. // Iranian Journal of Cancer Prevention;Jan2012, Vol. 5 Issue 1, p46 

    Osteosarcoma may rarely originate from the axial bones such as pelvis or vertebrae. In some pelvic and most vertebral primary tumors, resection often is not possible completely. In general, these tumors cannot be resected with negative margins so they need additional radiotherapy and...

  • Osteosarcoma of the larynx. Sawicki, Piotr; Każmierczak, Wojciech; Szylberg, Łukasz; Marszałek, Andrzej // Contemporary Oncology / Wspolczesna Onkologia;2015, Vol. 19 Issue 3, p246 

    Malignant neoplasms of the larynx are divided into epithelial and non-epithelial. Non-epithelial neoplasms include, among others, mesenchymal chondrosarcomas and osteosarcomas. Few cases of laryngeal osteosarcomas described in the literature were usually treated by surgery without the need to...

  • Concurrent Chemoradiotherapy vs Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: Phase III Randomized Trial. Chen, Qiu-Yan; Wen, Yue-Feng; Guo, Ling; Liu, Huai; Huang, Pei-Yu; Mo, Hao-Yuan; Li, Ning-Wei; Xiang, Yan-Qun; Luo, Dong-Hua; Qiu, Fang; Sun, Rui; Deng, Man-Quan; Chen, Ming-Yuan; Hua, Yi-Jun; Guo, Xiang; Cao, Ka-Jia; Hong, Ming-Huang; Qian, Chao-Nan; Mai, Hai-Qiang // JNCI: Journal of the National Cancer Institute;Dec2011, Vol. 103 Issue 23, p1761 

    Background Concurrent chemoradiotherapy (CCRT) has been shown to improve outcomes for stage III–IV nasopharyngeal carcinoma (NPC) patients compared with radiotherapy (RT) alone, but the effectiveness of the combined therapy for stage II NPC patients is unknown. Methods Patients with...

  • Embryonal rhabdomyosarcoma of the biliary tree mimicking a choledochal cyst. Nemade, Bhushan; Talapatra, Kaustav; Shet, Tanuja; Banavali, Shripad; Muckaden, Mary Ann; Laskar, Siddhartha // Journal of Cancer Research & Therapeutics;Jan-Mar2007, Vol. 3 Issue 1, p40 

    Embryonal rhabdomyosarcoma (ERMS) of biliary tree is a rare type of mesenchymal neoplasm diagnosed at surgery or by preoperative liver biopsy. We present a one year eight months old child who mimicked a choledochal cyst and was eventually treated with surgery, chemotherapy with IRS IV protocol...

  • Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates. Lin, J-C; Jan, J-S; Hsu, C-Y; Jiang, R-S; Wang, W-Y // British Journal of Cancer;1/27/2003, Vol. 88 Issue 2, p187 

    Nasopharyngeal carcinoma (NPC) is a radiosensitive and chemosensitive tumoun The aim of this prospective study is to evaluate the toxicity and efficacy of an outpatient weekly neoadjuvant chemotherapy (NeoCT) plus radiotherapy for advanced NPC. From November 1998 to August 2001, 90 NPC patients...

  • TREATMENT OF NON-METASTATIC HIGH-GRADE OSTEOSARCOMA. Samardziski, M.; Zafiroski, G.; Tolevska, C.; Zafirova-Ivanovska, B.; Kostadinova-Kunovska, S.; Kalicanin-Markovska, M. // Contributions of Macedonian Academy of Sciences & Arts;2008, Vol. 29 Issue 2, p309 

    The aim of this study is to improve 3-years survival rates and functional outcome in high-grade osteosarcoma patients treated with amputations and limb-sparing surgery, introducing Scandinavian Sarcoma Group chemotherapy protocol (SSG XVI). Patients and methods: During the period 2000-2005,...

  • High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma. Sauerbrey, A; Bielack, S; Kempf-Bielack, B; Zoubek, A; Paulussen, M; Zintl, F // Bone Marrow Transplantation;5/1/2001, Vol. 27 Issue 9, p933 

    In this report, we describe our experience with high-dose chemotherapy (HDC) and autologous stem cell transplantation (ASCT) in 15 children with relapsed osteosarcoma who were treated by members of the Cooperative Osteosarcoma Study Group. Eight patients received HDC after the first relapse, six...

  • Reconstrucción de tibia distal y artrodesis de tobillo en osteosarcoma (Cirugía de salvamento). Presentación de un caso. Castro, José Antonio Enríquez; Hernández, Mercedes; Sierra, Alejandro Cedillo; Méndez, Josefina Molina; Macías C., Carlos Roberto // Acta Ortopedica Mexicana;sep/oct2007, Vol. 21 Issue 5, p289 

    Treatment of bone sarcomas is aimed in healing and secondarily rescuing the limb. With the use of chemotherapy, radiation therapy, new prostheses and availability of graft, now most tumors can be resected, reducing functional deficit. Objective: To present a surgical option in management of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics